nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzphetamine—Toremifene—breast cancer	0.271	0.614	CrCtD
Benzphetamine—Tamoxifen—breast cancer	0.17	0.386	CrCtD
Benzphetamine—CYP3A4—breast cancer	0.0568	1	CbGaD
Benzphetamine—POR—Doxorubicin—breast cancer	0.0296	0.179	CbGbCtD
Benzphetamine—CYP2B6—Thiotepa—breast cancer	0.0204	0.123	CbGbCtD
Benzphetamine—Naftifine—Toremifene—breast cancer	0.0201	0.0779	CrCrCtD
Benzphetamine—Tamoxifen—Toremifene—breast cancer	0.0166	0.0646	CrCrCtD
Benzphetamine—Toremifene—Tamoxifen—breast cancer	0.0152	0.0591	CrCrCtD
Benzphetamine—Doxylamine—Toremifene—breast cancer	0.0139	0.0541	CrCrCtD
Benzphetamine—CYP2B6—Raloxifene—breast cancer	0.0136	0.0823	CbGbCtD
Benzphetamine—Phenoxybenzamine—Toremifene—breast cancer	0.0132	0.0513	CrCrCtD
Benzphetamine—Dextropropoxyphene—Toremifene—breast cancer	0.0132	0.0513	CrCrCtD
Benzphetamine—Naftifine—Tamoxifen—breast cancer	0.0126	0.0489	CrCrCtD
Benzphetamine—Bromodiphenhydramine—Toremifene—breast cancer	0.0118	0.0457	CrCrCtD
Benzphetamine—CYP3A4—Exemestane—breast cancer	0.0109	0.066	CbGbCtD
Benzphetamine—Levomethadyl Acetate—Tamoxifen—breast cancer	0.0101	0.0393	CrCrCtD
Benzphetamine—Methadyl Acetate—Tamoxifen—breast cancer	0.0101	0.0393	CrCrCtD
Benzphetamine—Clofedanol—Toremifene—breast cancer	0.00956	0.0371	CrCrCtD
Benzphetamine—Cyclobenzaprine—Tamoxifen—breast cancer	0.00951	0.0369	CrCrCtD
Benzphetamine—CYP3A4—Letrozole—breast cancer	0.00928	0.0561	CbGbCtD
Benzphetamine—Orphenadrine—Toremifene—breast cancer	0.00925	0.0359	CrCrCtD
Benzphetamine—CYP2B6—Tamoxifen—breast cancer	0.00899	0.0544	CbGbCtD
Benzphetamine—Doxylamine—Tamoxifen—breast cancer	0.00874	0.0339	CrCrCtD
Benzphetamine—Benzyl Benzoate—Toremifene—breast cancer	0.00857	0.0333	CrCrCtD
Benzphetamine—Phenoxybenzamine—Tamoxifen—breast cancer	0.0083	0.0322	CrCrCtD
Benzphetamine—Dextropropoxyphene—Tamoxifen—breast cancer	0.0083	0.0322	CrCrCtD
Benzphetamine—CYP3A4—Anastrozole—breast cancer	0.00827	0.05	CbGbCtD
Benzphetamine—Diphenhydramine—Toremifene—breast cancer	0.00821	0.0319	CrCrCtD
Benzphetamine—Tripelennamine—Tamoxifen—breast cancer	0.00791	0.0307	CrCrCtD
Benzphetamine—CYP3A4—Toremifene—breast cancer	0.00756	0.0457	CbGbCtD
Benzphetamine—Bromodiphenhydramine—Tamoxifen—breast cancer	0.00739	0.0287	CrCrCtD
Benzphetamine—CYP3A4—Fulvestrant—breast cancer	0.00703	0.0425	CbGbCtD
Benzphetamine—Methadone—Tamoxifen—breast cancer	0.00694	0.027	CrCrCtD
Benzphetamine—CYP2B6—Irinotecan—breast cancer	0.00691	0.0418	CbGbCtD
Benzphetamine—CYP3A4—Thiotepa—breast cancer	0.00627	0.0379	CbGbCtD
Benzphetamine—Clofedanol—Tamoxifen—breast cancer	0.006	0.0233	CrCrCtD
Benzphetamine—Orphenadrine—Tamoxifen—breast cancer	0.00581	0.0226	CrCrCtD
Benzphetamine—CYP3A4—Ixabepilone—breast cancer	0.00573	0.0347	CbGbCtD
Benzphetamine—Promazine—Tamoxifen—breast cancer	0.00554	0.0215	CrCrCtD
Benzphetamine—CYP3A4—Lapatinib—breast cancer	0.00552	0.0334	CbGbCtD
Benzphetamine—Benzyl Benzoate—Tamoxifen—breast cancer	0.00538	0.0209	CrCrCtD
Benzphetamine—Diphenhydramine—Tamoxifen—breast cancer	0.00516	0.02	CrCrCtD
Benzphetamine—CYP3A4—Raloxifene—breast cancer	0.00418	0.0253	CbGbCtD
Benzphetamine—CYP2B6—Doxorubicin—breast cancer	0.00377	0.0228	CbGbCtD
Benzphetamine—CYP3A4—Vinorelbine—breast cancer	0.00306	0.0185	CbGbCtD
Benzphetamine—CYP3A4—Tamoxifen—breast cancer	0.00276	0.0167	CbGbCtD
Benzphetamine—CYP3A4—Mitoxantrone—breast cancer	0.00269	0.0163	CbGbCtD
Benzphetamine—CYP3A4—Paclitaxel—breast cancer	0.00215	0.013	CbGbCtD
Benzphetamine—CYP3A4—Irinotecan—breast cancer	0.00212	0.0128	CbGbCtD
Benzphetamine—CYP3A4—Vinblastine—breast cancer	0.00189	0.0114	CbGbCtD
Benzphetamine—CYP3A4—Docetaxel—breast cancer	0.00155	0.0094	CbGbCtD
Benzphetamine—CYP3A4—Doxorubicin—breast cancer	0.00116	0.00701	CbGbCtD
Benzphetamine—POR—nipple—breast cancer	0.00053	0.0734	CbGeAlD
Benzphetamine—POR—endometrium—breast cancer	0.00032	0.0443	CbGeAlD
Benzphetamine—SLC18A2—endometrium—breast cancer	0.000305	0.0423	CbGeAlD
Benzphetamine—POR—pituitary gland—breast cancer	0.00029	0.0401	CbGeAlD
Benzphetamine—POR—adipose tissue—breast cancer	0.000288	0.04	CbGeAlD
Benzphetamine—SLC18A2—uterus—breast cancer	0.000281	0.0389	CbGeAlD
Benzphetamine—SLC18A2—adipose tissue—breast cancer	0.000275	0.0381	CbGeAlD
Benzphetamine—POR—adrenal gland—breast cancer	0.000259	0.0358	CbGeAlD
Benzphetamine—SLC18A2—female reproductive system—breast cancer	0.000253	0.035	CbGeAlD
Benzphetamine—POR—bone marrow—breast cancer	0.00025	0.0347	CbGeAlD
Benzphetamine—SLC18A2—adrenal gland—breast cancer	0.000247	0.0342	CbGeAlD
Benzphetamine—POR—female gonad—breast cancer	0.000241	0.0334	CbGeAlD
Benzphetamine—POR—endocrine gland—breast cancer	0.000224	0.0311	CbGeAlD
Benzphetamine—ADRA2A—nipple—breast cancer	0.000218	0.0302	CbGeAlD
Benzphetamine—SLC18A2—endocrine gland—breast cancer	0.000214	0.0296	CbGeAlD
Benzphetamine—ADRA1A—epithelium—breast cancer	0.000193	0.0267	CbGeAlD
Benzphetamine—Tamoxifen—ESRRA—breast cancer	0.00017	0.096	CrCbGaD
Benzphetamine—Decreased appetite—Anastrozole—breast cancer	0.00017	0.00395	CcSEcCtD
Benzphetamine—Decreased appetite—Letrozole—breast cancer	0.00017	0.00395	CcSEcCtD
Benzphetamine—Agitation—Chlorambucil—breast cancer	0.000169	0.00393	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Anastrozole—breast cancer	0.000169	0.00392	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Letrozole—breast cancer	0.000169	0.00392	CcSEcCtD
Benzphetamine—Insomnia—Raloxifene—breast cancer	0.000168	0.0039	CcSEcCtD
Benzphetamine—Dizziness—Fulvestrant—breast cancer	0.000167	0.00389	CcSEcCtD
Benzphetamine—Dizziness—Toremifene—breast cancer	0.000165	0.00384	CcSEcCtD
Benzphetamine—Nausea—Lapatinib—breast cancer	0.000163	0.0038	CcSEcCtD
Benzphetamine—Dyspepsia—Raloxifene—breast cancer	0.000163	0.0038	CcSEcCtD
Benzphetamine—Hypersensitivity—Exemestane—breast cancer	0.000162	0.00377	CcSEcCtD
Benzphetamine—Decreased appetite—Idarubicin—breast cancer	0.000161	0.00375	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Raloxifene—breast cancer	0.00016	0.00372	CcSEcCtD
Benzphetamine—Headache—Fulvestrant—breast cancer	0.000158	0.00369	CcSEcCtD
Benzphetamine—Headache—Toremifene—breast cancer	0.000156	0.00364	CcSEcCtD
Benzphetamine—ADRA1A—adipose tissue—breast cancer	0.000156	0.0216	CbGeAlD
Benzphetamine—Urticaria—Anastrozole—breast cancer	0.000155	0.00361	CcSEcCtD
Benzphetamine—Urticaria—Letrozole—breast cancer	0.000155	0.00361	CcSEcCtD
Benzphetamine—POR—lymph node—breast cancer	0.000155	0.0215	CbGeAlD
Benzphetamine—SLC6A2—female reproductive system—breast cancer	0.000154	0.0214	CbGeAlD
Benzphetamine—Hypersensitivity—Ixabepilone—breast cancer	0.000153	0.00356	CcSEcCtD
Benzphetamine—SLC6A2—adrenal gland—breast cancer	0.00015	0.0208	CbGeAlD
Benzphetamine—Diarrhoea—Exemestane—breast cancer	0.00015	0.0035	CcSEcCtD
Benzphetamine—Nausea—Fulvestrant—breast cancer	0.00015	0.0035	CcSEcCtD
Benzphetamine—Nausea—Toremifene—breast cancer	0.000148	0.00345	CcSEcCtD
Benzphetamine—SLC18A2—lymph node—breast cancer	0.000148	0.0205	CbGeAlD
Benzphetamine—Urticaria—Idarubicin—breast cancer	0.000147	0.00343	CcSEcCtD
Benzphetamine—CYP2B6—skin of body—breast cancer	0.000145	0.0202	CbGeAlD
Benzphetamine—Dizziness—Exemestane—breast cancer	0.000145	0.00338	CcSEcCtD
Benzphetamine—Hypersensitivity—Anastrozole—breast cancer	0.000144	0.00335	CcSEcCtD
Benzphetamine—Anorexia—Chlorambucil—breast cancer	0.000143	0.00333	CcSEcCtD
Benzphetamine—Diarrhoea—Ixabepilone—breast cancer	0.000142	0.0033	CcSEcCtD
Benzphetamine—Sweating—Irinotecan—breast cancer	0.000142	0.0033	CcSEcCtD
Benzphetamine—Sweating—Mitoxantrone—breast cancer	0.000142	0.0033	CcSEcCtD
Benzphetamine—ADRA1A—adrenal gland—breast cancer	0.00014	0.0194	CbGeAlD
Benzphetamine—Palpitations—Goserelin—breast cancer	0.000138	0.00322	CcSEcCtD
Benzphetamine—Sweating—Gemcitabine—breast cancer	0.000138	0.00321	CcSEcCtD
Benzphetamine—Headache—Exemestane—breast cancer	0.000138	0.0032	CcSEcCtD
Benzphetamine—Dizziness—Ixabepilone—breast cancer	0.000137	0.00319	CcSEcCtD
Benzphetamine—Hypersensitivity—Idarubicin—breast cancer	0.000137	0.00318	CcSEcCtD
Benzphetamine—Diarrhoea—Anastrozole—breast cancer	0.000134	0.00311	CcSEcCtD
Benzphetamine—Diarrhoea—Letrozole—breast cancer	0.000134	0.00311	CcSEcCtD
Benzphetamine—Dyspepsia—Chlorambucil—breast cancer	0.000132	0.00307	CcSEcCtD
Benzphetamine—ADRA2A—endometrium—breast cancer	0.000132	0.0182	CbGeAlD
Benzphetamine—Anorexia—Vinblastine—breast cancer	0.000131	0.00305	CcSEcCtD
Benzphetamine—Nausea—Exemestane—breast cancer	0.000131	0.00304	CcSEcCtD
Benzphetamine—SLC6A2—endocrine gland—breast cancer	0.00013	0.0181	CbGeAlD
Benzphetamine—Decreased appetite—Chlorambucil—breast cancer	0.00013	0.00304	CcSEcCtD
Benzphetamine—Headache—Ixabepilone—breast cancer	0.00013	0.00302	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Chlorambucil—breast cancer	0.00013	0.00302	CcSEcCtD
Benzphetamine—Hyperhidrosis—Tamoxifen—breast cancer	0.000129	0.00301	CcSEcCtD
Benzphetamine—Dizziness—Anastrozole—breast cancer	0.000129	0.003	CcSEcCtD
Benzphetamine—Dizziness—Letrozole—breast cancer	0.000129	0.003	CcSEcCtD
Benzphetamine—Tamoxifen—SULT1A1—breast cancer	0.000129	0.0727	CrCbGaD
Benzphetamine—Tachycardia—Melphalan—breast cancer	0.000128	0.00297	CcSEcCtD
Benzphetamine—Anorexia—Tamoxifen—breast cancer	0.000127	0.00296	CcSEcCtD
Benzphetamine—Diarrhoea—Idarubicin—breast cancer	0.000127	0.00295	CcSEcCtD
Benzphetamine—Diarrhoea—Raloxifene—breast cancer	0.000127	0.00295	CcSEcCtD
Benzphetamine—Anorexia—Melphalan—breast cancer	0.000125	0.0029	CcSEcCtD
Benzphetamine—Tachycardia—Goserelin—breast cancer	0.000125	0.0029	CcSEcCtD
Benzphetamine—Palpitations—Vinorelbine—breast cancer	0.000124	0.00288	CcSEcCtD
Benzphetamine—Hyperhidrosis—Goserelin—breast cancer	0.000123	0.00287	CcSEcCtD
Benzphetamine—Nausea—Ixabepilone—breast cancer	0.000123	0.00287	CcSEcCtD
Benzphetamine—Agitation—Thiotepa—breast cancer	0.000123	0.00286	CcSEcCtD
Benzphetamine—Dizziness—Raloxifene—breast cancer	0.000123	0.00285	CcSEcCtD
Benzphetamine—Headache—Anastrozole—breast cancer	0.000122	0.00285	CcSEcCtD
Benzphetamine—Headache—Letrozole—breast cancer	0.000122	0.00285	CcSEcCtD
Benzphetamine—Anorexia—Goserelin—breast cancer	0.000122	0.00283	CcSEcCtD
Benzphetamine—ADRA1A—endocrine gland—breast cancer	0.000121	0.0168	CbGeAlD
Benzphetamine—ADRA2A—uterus—breast cancer	0.000121	0.0168	CbGeAlD
Benzphetamine—Insomnia—Tamoxifen—breast cancer	0.000121	0.00281	CcSEcCtD
Benzphetamine—Decreased appetite—Vinblastine—breast cancer	0.00012	0.00278	CcSEcCtD
Benzphetamine—Urticaria—Chlorambucil—breast cancer	0.000119	0.00277	CcSEcCtD
Benzphetamine—ADRA2A—pituitary gland—breast cancer	0.000119	0.0165	CbGeAlD
Benzphetamine—ADRA2A—adipose tissue—breast cancer	0.000119	0.0164	CbGeAlD
Benzphetamine—Dyspepsia—Tamoxifen—breast cancer	0.000118	0.00274	CcSEcCtD
Benzphetamine—Decreased appetite—Tamoxifen—breast cancer	0.000116	0.0027	CcSEcCtD
Benzphetamine—Headache—Idarubicin—breast cancer	0.000116	0.0027	CcSEcCtD
Benzphetamine—Headache—Raloxifene—breast cancer	0.000116	0.0027	CcSEcCtD
Benzphetamine—Nausea—Anastrozole—breast cancer	0.000116	0.0027	CcSEcCtD
Benzphetamine—Nausea—Letrozole—breast cancer	0.000116	0.0027	CcSEcCtD
Benzphetamine—Insomnia—Goserelin—breast cancer	0.000115	0.00269	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Tamoxifen—breast cancer	0.000115	0.00268	CcSEcCtD
Benzphetamine—Dyspepsia—Melphalan—breast cancer	0.000115	0.00268	CcSEcCtD
Benzphetamine—Decreased appetite—Melphalan—breast cancer	0.000114	0.00265	CcSEcCtD
Benzphetamine—CYP2B6—female reproductive system—breast cancer	0.000114	0.0157	CbGeAlD
Benzphetamine—Gastrointestinal disorder—Melphalan—breast cancer	0.000113	0.00263	CcSEcCtD
Benzphetamine—Dyspepsia—Goserelin—breast cancer	0.000112	0.00261	CcSEcCtD
Benzphetamine—Tachycardia—Vinorelbine—breast cancer	0.000112	0.0026	CcSEcCtD
Benzphetamine—Decreased appetite—Goserelin—breast cancer	0.000111	0.00258	CcSEcCtD
Benzphetamine—CYP2B6—adrenal gland—breast cancer	0.000111	0.0154	CbGeAlD
Benzphetamine—Hypersensitivity—Chlorambucil—breast cancer	0.000111	0.00257	CcSEcCtD
Benzphetamine—Nausea—Idarubicin—breast cancer	0.00011	0.00256	CcSEcCtD
Benzphetamine—Nausea—Raloxifene—breast cancer	0.00011	0.00256	CcSEcCtD
Benzphetamine—ADRA2A—female reproductive system—breast cancer	0.000109	0.0151	CbGeAlD
Benzphetamine—Anorexia—Vinorelbine—breast cancer	0.000109	0.00254	CcSEcCtD
Benzphetamine—Tachycardia—Thiotepa—breast cancer	0.000107	0.00248	CcSEcCtD
Benzphetamine—ADRA2A—adrenal gland—breast cancer	0.000106	0.0147	CbGeAlD
Benzphetamine—Urticaria—Tamoxifen—breast cancer	0.000106	0.00247	CcSEcCtD
Benzphetamine—Anorexia—Thiotepa—breast cancer	0.000104	0.00242	CcSEcCtD
Benzphetamine—Urticaria—Melphalan—breast cancer	0.000104	0.00242	CcSEcCtD
Benzphetamine—Diarrhoea—Chlorambucil—breast cancer	0.000103	0.00239	CcSEcCtD
Benzphetamine—Urticaria—Goserelin—breast cancer	0.000101	0.00236	CcSEcCtD
Benzphetamine—Hypersensitivity—Vinblastine—breast cancer	0.000101	0.00236	CcSEcCtD
Benzphetamine—Decreased appetite—Vinorelbine—breast cancer	9.93e-05	0.00231	CcSEcCtD
Benzphetamine—ADRA2A—female gonad—breast cancer	9.92e-05	0.0137	CbGeAlD
Benzphetamine—Gastrointestinal disorder—Vinorelbine—breast cancer	9.87e-05	0.0023	CcSEcCtD
Benzphetamine—Hypersensitivity—Tamoxifen—breast cancer	9.84e-05	0.00229	CcSEcCtD
Benzphetamine—Hypersensitivity—Melphalan—breast cancer	9.64e-05	0.00224	CcSEcCtD
Benzphetamine—CYP2B6—endocrine gland—breast cancer	9.61e-05	0.0133	CbGeAlD
Benzphetamine—Dyspepsia—Thiotepa—breast cancer	9.61e-05	0.00224	CcSEcCtD
Benzphetamine—Decreased appetite—Thiotepa—breast cancer	9.49e-05	0.00221	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Thiotepa—breast cancer	9.42e-05	0.00219	CcSEcCtD
Benzphetamine—Diarrhoea—Vinblastine—breast cancer	9.41e-05	0.00219	CcSEcCtD
Benzphetamine—Hypersensitivity—Goserelin—breast cancer	9.4e-05	0.00219	CcSEcCtD
Benzphetamine—ADRA2A—endocrine gland—breast cancer	9.22e-05	0.0128	CbGeAlD
Benzphetamine—Tachycardia—Mitoxantrone—breast cancer	9.2e-05	0.00214	CcSEcCtD
Benzphetamine—Diarrhoea—Tamoxifen—breast cancer	9.14e-05	0.00213	CcSEcCtD
Benzphetamine—Hyperhidrosis—Mitoxantrone—breast cancer	9.11e-05	0.00212	CcSEcCtD
Benzphetamine—Hyperhidrosis—Irinotecan—breast cancer	9.11e-05	0.00212	CcSEcCtD
Benzphetamine—Dizziness—Vinblastine—breast cancer	9.09e-05	0.00212	CcSEcCtD
Benzphetamine—Urticaria—Vinorelbine—breast cancer	9.08e-05	0.00211	CcSEcCtD
Benzphetamine—SLC6A2—lymph node—breast cancer	9.02e-05	0.0125	CbGeAlD
Benzphetamine—Anorexia—Irinotecan—breast cancer	8.98e-05	0.00209	CcSEcCtD
Benzphetamine—Anorexia—Mitoxantrone—breast cancer	8.98e-05	0.00209	CcSEcCtD
Benzphetamine—Diarrhoea—Melphalan—breast cancer	8.95e-05	0.00208	CcSEcCtD
Benzphetamine—Nausea—Chlorambucil—breast cancer	8.91e-05	0.00207	CcSEcCtD
Benzphetamine—Hyperhidrosis—Gemcitabine—breast cancer	8.88e-05	0.00207	CcSEcCtD
Benzphetamine—Dizziness—Tamoxifen—breast cancer	8.83e-05	0.00206	CcSEcCtD
Benzphetamine—Tremor—Paclitaxel—breast cancer	8.82e-05	0.00205	CcSEcCtD
Benzphetamine—Tachycardia—Fluorouracil—breast cancer	8.81e-05	0.00205	CcSEcCtD
Benzphetamine—Anorexia—Gemcitabine—breast cancer	8.75e-05	0.00204	CcSEcCtD
Benzphetamine—Diarrhoea—Goserelin—breast cancer	8.73e-05	0.00203	CcSEcCtD
Benzphetamine—Urticaria—Thiotepa—breast cancer	8.67e-05	0.00202	CcSEcCtD
Benzphetamine—Agitation—Paclitaxel—breast cancer	8.65e-05	0.00201	CcSEcCtD
Benzphetamine—Headache—Vinblastine—breast cancer	8.61e-05	0.00201	CcSEcCtD
Benzphetamine—Anorexia—Fluorouracil—breast cancer	8.6e-05	0.002	CcSEcCtD
Benzphetamine—CYP3A4—female reproductive system—breast cancer	8.58e-05	0.0119	CbGeAlD
Benzphetamine—Insomnia—Irinotecan—breast cancer	8.52e-05	0.00198	CcSEcCtD
Benzphetamine—Dizziness—Goserelin—breast cancer	8.44e-05	0.00196	CcSEcCtD
Benzphetamine—Hypersensitivity—Vinorelbine—breast cancer	8.42e-05	0.00196	CcSEcCtD
Benzphetamine—Headache—Tamoxifen—breast cancer	8.37e-05	0.00195	CcSEcCtD
Benzphetamine—Palpitations—Paclitaxel—breast cancer	8.32e-05	0.00194	CcSEcCtD
Benzphetamine—Insomnia—Gemcitabine—breast cancer	8.3e-05	0.00193	CcSEcCtD
Benzphetamine—Dyspepsia—Mitoxantrone—breast cancer	8.3e-05	0.00193	CcSEcCtD
Benzphetamine—Dyspepsia—Irinotecan—breast cancer	8.3e-05	0.00193	CcSEcCtD
Benzphetamine—Decreased appetite—Irinotecan—breast cancer	8.19e-05	0.00191	CcSEcCtD
Benzphetamine—Decreased appetite—Mitoxantrone—breast cancer	8.19e-05	0.00191	CcSEcCtD
Benzphetamine—Nausea—Vinblastine—breast cancer	8.17e-05	0.0019	CcSEcCtD
Benzphetamine—Insomnia—Fluorouracil—breast cancer	8.16e-05	0.0019	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Irinotecan—breast cancer	8.14e-05	0.00189	CcSEcCtD
Benzphetamine—Hypersensitivity—Thiotepa—breast cancer	8.04e-05	0.00187	CcSEcCtD
Benzphetamine—Headache—Goserelin—breast cancer	7.99e-05	0.00186	CcSEcCtD
Benzphetamine—Decreased appetite—Gemcitabine—breast cancer	7.98e-05	0.00186	CcSEcCtD
Benzphetamine—Dyspepsia—Fluorouracil—breast cancer	7.95e-05	0.00185	CcSEcCtD
Benzphetamine—Nausea—Tamoxifen—breast cancer	7.93e-05	0.00185	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Gemcitabine—breast cancer	7.93e-05	0.00184	CcSEcCtD
Benzphetamine—Decreased appetite—Fluorouracil—breast cancer	7.85e-05	0.00183	CcSEcCtD
Benzphetamine—Diarrhoea—Vinorelbine—breast cancer	7.82e-05	0.00182	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Fluorouracil—breast cancer	7.79e-05	0.00181	CcSEcCtD
Benzphetamine—Nausea—Melphalan—breast cancer	7.77e-05	0.00181	CcSEcCtD
Benzphetamine—Nausea—Goserelin—breast cancer	7.58e-05	0.00176	CcSEcCtD
Benzphetamine—Dizziness—Vinorelbine—breast cancer	7.56e-05	0.00176	CcSEcCtD
Benzphetamine—Trimethaphan—BCHE—breast cancer	7.51e-05	0.0424	CrCbGaD
Benzphetamine—Tachycardia—Paclitaxel—breast cancer	7.5e-05	0.00175	CcSEcCtD
Benzphetamine—Urticaria—Mitoxantrone—breast cancer	7.49e-05	0.00174	CcSEcCtD
Benzphetamine—Diarrhoea—Thiotepa—breast cancer	7.47e-05	0.00174	CcSEcCtD
Benzphetamine—Hyperhidrosis—Paclitaxel—breast cancer	7.43e-05	0.00173	CcSEcCtD
Benzphetamine—Anorexia—Paclitaxel—breast cancer	7.33e-05	0.00171	CcSEcCtD
Benzphetamine—CYP3A4—endocrine gland—breast cancer	7.26e-05	0.0101	CbGeAlD
Benzphetamine—Tremor—Capecitabine—breast cancer	7.24e-05	0.00169	CcSEcCtD
Benzphetamine—Dizziness—Thiotepa—breast cancer	7.22e-05	0.00168	CcSEcCtD
Benzphetamine—Urticaria—Fluorouracil—breast cancer	7.17e-05	0.00167	CcSEcCtD
Benzphetamine—Headache—Vinorelbine—breast cancer	7.16e-05	0.00167	CcSEcCtD
Benzphetamine—Sweating—Methotrexate—breast cancer	7.06e-05	0.00164	CcSEcCtD
Benzphetamine—Palpitations—Docetaxel—breast cancer	7.05e-05	0.00164	CcSEcCtD
Benzphetamine—Insomnia—Paclitaxel—breast cancer	6.95e-05	0.00162	CcSEcCtD
Benzphetamine—Hypersensitivity—Mitoxantrone—breast cancer	6.94e-05	0.00162	CcSEcCtD
Benzphetamine—Hypersensitivity—Irinotecan—breast cancer	6.94e-05	0.00162	CcSEcCtD
Benzphetamine—Headache—Thiotepa—breast cancer	6.84e-05	0.00159	CcSEcCtD
Benzphetamine—Palpitations—Capecitabine—breast cancer	6.83e-05	0.00159	CcSEcCtD
Benzphetamine—Nausea—Vinorelbine—breast cancer	6.79e-05	0.00158	CcSEcCtD
Benzphetamine—Dyspepsia—Paclitaxel—breast cancer	6.77e-05	0.00157	CcSEcCtD
Benzphetamine—Decreased appetite—Paclitaxel—breast cancer	6.68e-05	0.00156	CcSEcCtD
Benzphetamine—Hypersensitivity—Fluorouracil—breast cancer	6.65e-05	0.00155	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Paclitaxel—breast cancer	6.64e-05	0.00154	CcSEcCtD
Benzphetamine—Sweating—Epirubicin—breast cancer	6.61e-05	0.00154	CcSEcCtD
Benzphetamine—Nausea—Thiotepa—breast cancer	6.48e-05	0.00151	CcSEcCtD
Benzphetamine—Diarrhoea—Irinotecan—breast cancer	6.45e-05	0.0015	CcSEcCtD
Benzphetamine—Diarrhoea—Mitoxantrone—breast cancer	6.45e-05	0.0015	CcSEcCtD
Benzphetamine—ADRA2A—lymph node—breast cancer	6.37e-05	0.00883	CbGeAlD
Benzphetamine—Tachycardia—Docetaxel—breast cancer	6.36e-05	0.00148	CcSEcCtD
Benzphetamine—Diarrhoea—Gemcitabine—breast cancer	6.28e-05	0.00146	CcSEcCtD
Benzphetamine—Dizziness—Irinotecan—breast cancer	6.23e-05	0.00145	CcSEcCtD
Benzphetamine—Anorexia—Docetaxel—breast cancer	6.21e-05	0.00145	CcSEcCtD
Benzphetamine—Diarrhoea—Fluorouracil—breast cancer	6.18e-05	0.00144	CcSEcCtD
Benzphetamine—Tachycardia—Capecitabine—breast cancer	6.16e-05	0.00143	CcSEcCtD
Benzphetamine—Sweating—Doxorubicin—breast cancer	6.11e-05	0.00142	CcSEcCtD
Benzphetamine—Urticaria—Paclitaxel—breast cancer	6.11e-05	0.00142	CcSEcCtD
Benzphetamine—Hyperhidrosis—Capecitabine—breast cancer	6.1e-05	0.00142	CcSEcCtD
Benzphetamine—Anorexia—Capecitabine—breast cancer	6.01e-05	0.0014	CcSEcCtD
Benzphetamine—Dizziness—Fluorouracil—breast cancer	5.97e-05	0.00139	CcSEcCtD
Benzphetamine—Headache—Mitoxantrone—breast cancer	5.9e-05	0.00137	CcSEcCtD
Benzphetamine—Headache—Irinotecan—breast cancer	5.9e-05	0.00137	CcSEcCtD
Benzphetamine—Insomnia—Docetaxel—breast cancer	5.89e-05	0.00137	CcSEcCtD
Benzphetamine—Headache—Gemcitabine—breast cancer	5.75e-05	0.00134	CcSEcCtD
Benzphetamine—Dyspepsia—Docetaxel—breast cancer	5.73e-05	0.00133	CcSEcCtD
Benzphetamine—Insomnia—Capecitabine—breast cancer	5.71e-05	0.00133	CcSEcCtD
Benzphetamine—Decreased appetite—Docetaxel—breast cancer	5.66e-05	0.00132	CcSEcCtD
Benzphetamine—Hypersensitivity—Paclitaxel—breast cancer	5.66e-05	0.00132	CcSEcCtD
Benzphetamine—Headache—Fluorouracil—breast cancer	5.65e-05	0.00132	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Docetaxel—breast cancer	5.62e-05	0.00131	CcSEcCtD
Benzphetamine—Nausea—Mitoxantrone—breast cancer	5.6e-05	0.0013	CcSEcCtD
Benzphetamine—Nausea—Irinotecan—breast cancer	5.6e-05	0.0013	CcSEcCtD
Benzphetamine—Toremifene—ESR1—breast cancer	5.6e-05	0.0316	CrCbGaD
Benzphetamine—Oxaprozin—PTGS1—breast cancer	5.58e-05	0.0315	CrCbGaD
Benzphetamine—Dyspepsia—Capecitabine—breast cancer	5.55e-05	0.00129	CcSEcCtD
Benzphetamine—Decreased appetite—Capecitabine—breast cancer	5.48e-05	0.00128	CcSEcCtD
Benzphetamine—Nausea—Gemcitabine—breast cancer	5.45e-05	0.00127	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Capecitabine—breast cancer	5.45e-05	0.00127	CcSEcCtD
Benzphetamine—Nausea—Fluorouracil—breast cancer	5.36e-05	0.00125	CcSEcCtD
Benzphetamine—Diarrhoea—Paclitaxel—breast cancer	5.26e-05	0.00122	CcSEcCtD
Benzphetamine—Dizziness—Paclitaxel—breast cancer	5.08e-05	0.00118	CcSEcCtD
Benzphetamine—Urticaria—Capecitabine—breast cancer	5.01e-05	0.00117	CcSEcCtD
Benzphetamine—Agitation—Epirubicin—breast cancer	4.95e-05	0.00115	CcSEcCtD
Benzphetamine—Headache—Paclitaxel—breast cancer	4.82e-05	0.00112	CcSEcCtD
Benzphetamine—Hypersensitivity—Docetaxel—breast cancer	4.8e-05	0.00112	CcSEcCtD
Benzphetamine—Ethopropazine—BCHE—breast cancer	4.78e-05	0.027	CrCbGaD
Benzphetamine—Palpitations—Epirubicin—breast cancer	4.76e-05	0.00111	CcSEcCtD
Benzphetamine—Hypersensitivity—Capecitabine—breast cancer	4.65e-05	0.00108	CcSEcCtD
Benzphetamine—Agitation—Doxorubicin—breast cancer	4.58e-05	0.00107	CcSEcCtD
Benzphetamine—Nausea—Paclitaxel—breast cancer	4.57e-05	0.00106	CcSEcCtD
Benzphetamine—Hyperhidrosis—Methotrexate—breast cancer	4.54e-05	0.00106	CcSEcCtD
Benzphetamine—Anorexia—Methotrexate—breast cancer	4.48e-05	0.00104	CcSEcCtD
Benzphetamine—Toremifene—CYP1A1—breast cancer	4.47e-05	0.0252	CrCbGaD
Benzphetamine—Diarrhoea—Docetaxel—breast cancer	4.46e-05	0.00104	CcSEcCtD
Benzphetamine—Palpitations—Doxorubicin—breast cancer	4.4e-05	0.00102	CcSEcCtD
Benzphetamine—Diarrhoea—Capecitabine—breast cancer	4.32e-05	0.001	CcSEcCtD
Benzphetamine—Dizziness—Docetaxel—breast cancer	4.31e-05	0.001	CcSEcCtD
Benzphetamine—Tachycardia—Epirubicin—breast cancer	4.29e-05	0.000998	CcSEcCtD
Benzphetamine—Hyperhidrosis—Epirubicin—breast cancer	4.25e-05	0.000989	CcSEcCtD
Benzphetamine—Insomnia—Methotrexate—breast cancer	4.25e-05	0.000989	CcSEcCtD
Benzphetamine—Orphenadrine—SCN10A—breast cancer	4.2e-05	0.0237	CrCbGaD
Benzphetamine—Anorexia—Epirubicin—breast cancer	4.19e-05	0.000975	CcSEcCtD
Benzphetamine—Dizziness—Capecitabine—breast cancer	4.17e-05	0.000971	CcSEcCtD
Benzphetamine—Dyspepsia—Methotrexate—breast cancer	4.13e-05	0.000962	CcSEcCtD
Benzphetamine—Levomethadyl Acetate—CYP19A1—breast cancer	4.11e-05	0.0232	CrCbGaD
Benzphetamine—Decreased appetite—Methotrexate—breast cancer	4.08e-05	0.00095	CcSEcCtD
Benzphetamine—Headache—Docetaxel—breast cancer	4.08e-05	0.00095	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Methotrexate—breast cancer	4.05e-05	0.000944	CcSEcCtD
Benzphetamine—Insomnia—Epirubicin—breast cancer	3.97e-05	0.000925	CcSEcCtD
Benzphetamine—Tachycardia—Doxorubicin—breast cancer	3.97e-05	0.000924	CcSEcCtD
Benzphetamine—Headache—Capecitabine—breast cancer	3.95e-05	0.00092	CcSEcCtD
Benzphetamine—Hyperhidrosis—Doxorubicin—breast cancer	3.93e-05	0.000915	CcSEcCtD
Benzphetamine—Anorexia—Doxorubicin—breast cancer	3.88e-05	0.000902	CcSEcCtD
Benzphetamine—Nausea—Docetaxel—breast cancer	3.87e-05	0.000901	CcSEcCtD
Benzphetamine—Dyspepsia—Epirubicin—breast cancer	3.87e-05	0.0009	CcSEcCtD
Benzphetamine—Decreased appetite—Epirubicin—breast cancer	3.82e-05	0.000889	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Epirubicin—breast cancer	3.79e-05	0.000883	CcSEcCtD
Benzphetamine—Nausea—Capecitabine—breast cancer	3.75e-05	0.000872	CcSEcCtD
Benzphetamine—Urticaria—Methotrexate—breast cancer	3.73e-05	0.000868	CcSEcCtD
Benzphetamine—Phenylbutazone—PTGS1—breast cancer	3.69e-05	0.0208	CrCbGaD
Benzphetamine—Insomnia—Doxorubicin—breast cancer	3.68e-05	0.000856	CcSEcCtD
Benzphetamine—Tamoxifen—ESR2—breast cancer	3.63e-05	0.0205	CrCbGaD
Benzphetamine—Dyspepsia—Doxorubicin—breast cancer	3.58e-05	0.000833	CcSEcCtD
Benzphetamine—Decreased appetite—Doxorubicin—breast cancer	3.53e-05	0.000823	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Doxorubicin—breast cancer	3.51e-05	0.000817	CcSEcCtD
Benzphetamine—Urticaria—Epirubicin—breast cancer	3.49e-05	0.000813	CcSEcCtD
Benzphetamine—Tripelennamine—CYP2D6—breast cancer	3.46e-05	0.0195	CrCbGaD
Benzphetamine—Hypersensitivity—Methotrexate—breast cancer	3.46e-05	0.000805	CcSEcCtD
Benzphetamine—Tamoxifen—CYP1B1—breast cancer	3.31e-05	0.0187	CrCbGaD
Benzphetamine—Hypersensitivity—Epirubicin—breast cancer	3.24e-05	0.000754	CcSEcCtD
Benzphetamine—Urticaria—Doxorubicin—breast cancer	3.23e-05	0.000752	CcSEcCtD
Benzphetamine—Diarrhoea—Methotrexate—breast cancer	3.21e-05	0.000748	CcSEcCtD
Benzphetamine—Oxaprozin—PTGS2—breast cancer	3.19e-05	0.018	CrCbGaD
Benzphetamine—Dizziness—Methotrexate—breast cancer	3.11e-05	0.000723	CcSEcCtD
Benzphetamine—Diarrhoea—Epirubicin—breast cancer	3.01e-05	0.0007	CcSEcCtD
Benzphetamine—Hypersensitivity—Doxorubicin—breast cancer	3e-05	0.000697	CcSEcCtD
Benzphetamine—Headache—Methotrexate—breast cancer	2.94e-05	0.000685	CcSEcCtD
Benzphetamine—Dizziness—Epirubicin—breast cancer	2.91e-05	0.000676	CcSEcCtD
Benzphetamine—Cyclobenzaprine—CYP2D6—breast cancer	2.88e-05	0.0162	CrCbGaD
Benzphetamine—Toremifene—CYP3A4—breast cancer	2.86e-05	0.0161	CrCbGaD
Benzphetamine—Nausea—Methotrexate—breast cancer	2.79e-05	0.000649	CcSEcCtD
Benzphetamine—Diarrhoea—Doxorubicin—breast cancer	2.78e-05	0.000648	CcSEcCtD
Benzphetamine—Headache—Epirubicin—breast cancer	2.75e-05	0.000641	CcSEcCtD
Benzphetamine—Dizziness—Doxorubicin—breast cancer	2.69e-05	0.000626	CcSEcCtD
Benzphetamine—Alimemazine—CYP3A4—breast cancer	2.68e-05	0.0151	CrCbGaD
Benzphetamine—Benzatropine—CYP2D6—breast cancer	2.66e-05	0.015	CrCbGaD
Benzphetamine—Nausea—Epirubicin—breast cancer	2.61e-05	0.000608	CcSEcCtD
Benzphetamine—Headache—Doxorubicin—breast cancer	2.55e-05	0.000593	CcSEcCtD
Benzphetamine—Cyclobenzaprine—CYP3A4—breast cancer	2.47e-05	0.0139	CrCbGaD
Benzphetamine—Tamoxifen—CYP19A1—breast cancer	2.43e-05	0.0137	CrCbGaD
Benzphetamine—Nausea—Doxorubicin—breast cancer	2.42e-05	0.000562	CcSEcCtD
Benzphetamine—Methadone—CYP19A1—breast cancer	2.41e-05	0.0136	CrCbGaD
Benzphetamine—Toremifene—ABCB1—breast cancer	2.38e-05	0.0134	CrCbGaD
Benzphetamine—Propafenone—CYP2D6—breast cancer	2.35e-05	0.0132	CrCbGaD
Benzphetamine—Phenprocoumon—CYP3A4—breast cancer	2.32e-05	0.0131	CrCbGaD
Benzphetamine—Dextroamphetamine—CYP2D6—breast cancer	2.3e-05	0.013	CrCbGaD
Benzphetamine—Tamoxifen—ABCG2—breast cancer	2.28e-05	0.0129	CrCbGaD
Benzphetamine—Tamoxifen—ESR1—breast cancer	2.23e-05	0.0126	CrCbGaD
Benzphetamine—Selegiline—CYP2D6—breast cancer	2.23e-05	0.0126	CrCbGaD
Benzphetamine—Phenylbutazone—CYP3A4—breast cancer	2.15e-05	0.0121	CrCbGaD
Benzphetamine—Phenylbutazone—PTGS2—breast cancer	2.11e-05	0.0119	CrCbGaD
Benzphetamine—Bepridil—CYP2D6—breast cancer	2.09e-05	0.0118	CrCbGaD
Benzphetamine—Phenprocoumon—ALB—breast cancer	2.02e-05	0.0114	CrCbGaD
Benzphetamine—Propafenone—CYP3A4—breast cancer	2.01e-05	0.0113	CrCbGaD
Benzphetamine—Diphenhydramine—PTGS1—breast cancer	2.01e-05	0.0113	CrCbGaD
Benzphetamine—Dextropropoxyphene—CYP2D6—breast cancer	1.94e-05	0.011	CrCbGaD
Benzphetamine—Levomethadyl Acetate—CYP3A4—breast cancer	1.93e-05	0.0109	CrCbGaD
Benzphetamine—Selegiline—CYP3A4—breast cancer	1.91e-05	0.0108	CrCbGaD
Benzphetamine—Amphetamine—CYP2D6—breast cancer	1.85e-05	0.0105	CrCbGaD
Benzphetamine—Tamoxifen—CYP1A1—breast cancer	1.79e-05	0.0101	CrCbGaD
Benzphetamine—Methamphetamine—CYP2D6—breast cancer	1.72e-05	0.00969	CrCbGaD
Benzphetamine—Atomoxetine—CYP2D6—breast cancer	1.69e-05	0.00954	CrCbGaD
Benzphetamine—Modafinil—CYP3A4—breast cancer	1.69e-05	0.00951	CrCbGaD
Benzphetamine—Propafenone—ABCB1—breast cancer	1.67e-05	0.00945	CrCbGaD
Benzphetamine—Dextropropoxyphene—CYP3A4—breast cancer	1.67e-05	0.0094	CrCbGaD
Benzphetamine—Fentanyl—CYP3A4—breast cancer	1.65e-05	0.0093	CrCbGaD
Benzphetamine—Selegiline—ABCB1—breast cancer	1.59e-05	0.00898	CrCbGaD
Benzphetamine—Phenytoin—CYP3A4—breast cancer	1.5e-05	0.00843	CrCbGaD
Benzphetamine—Bepridil—ABCB1—breast cancer	1.49e-05	0.00842	CrCbGaD
Benzphetamine—Atomoxetine—CYP3A4—breast cancer	1.45e-05	0.00818	CrCbGaD
Benzphetamine—Phenoxybenzamine—CYP3A4—breast cancer	1.4e-05	0.00788	CrCbGaD
Benzphetamine—Trimipramine—CYP2D6—breast cancer	1.39e-05	0.00784	CrCbGaD
Benzphetamine—Fentanyl—ABCB1—breast cancer	1.37e-05	0.00774	CrCbGaD
Benzphetamine—Diphenhydramine—CYP2D6—breast cancer	1.37e-05	0.0077	CrCbGaD
Benzphetamine—Promethazine—CYP2D6—breast cancer	1.34e-05	0.00755	CrCbGaD
Benzphetamine—Tamoxifen—CYP2D6—breast cancer	1.33e-05	0.0075	CrCbGaD
Benzphetamine—Methadone—CYP2D6—breast cancer	1.32e-05	0.00743	CrCbGaD
Benzphetamine—Phenytoin—ALB—breast cancer	1.3e-05	0.00736	CrCbGaD
Benzphetamine—Phenytoin—ABCB1—breast cancer	1.24e-05	0.00702	CrCbGaD
Benzphetamine—Trimipramine—CYP3A4—breast cancer	1.19e-05	0.00673	CrCbGaD
Benzphetamine—Tamoxifen—CYP3A4—breast cancer	1.14e-05	0.00643	CrCbGaD
Benzphetamine—Methadone—CYP3A4—breast cancer	1.13e-05	0.00638	CrCbGaD
Benzphetamine—Orphenadrine—CYP3A4—breast cancer	1.11e-05	0.00625	CrCbGaD
Benzphetamine—Promazine—CYP3A4—breast cancer	1.01e-05	0.0057	CrCbGaD
Benzphetamine—Trimipramine—ABCB1—breast cancer	9.93e-06	0.0056	CrCbGaD
Benzphetamine—Promethazine—ABCB1—breast cancer	9.56e-06	0.00539	CrCbGaD
Benzphetamine—Tamoxifen—ABCB1—breast cancer	9.49e-06	0.00535	CrCbGaD
Benzphetamine—Methadone—ABCB1—breast cancer	9.41e-06	0.00531	CrCbGaD
Benzphetamine—ADRA1A—Signaling Pathways—SMAD4—breast cancer	2.16e-06	8.09e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—PIK3CD—breast cancer	2.16e-06	8.06e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PDGFA—breast cancer	2.15e-06	8.05e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IGF1R—breast cancer	2.15e-06	8.04e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—CXCL8—breast cancer	2.14e-06	8e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—TGFBR2—breast cancer	2.12e-06	7.94e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—HES1—breast cancer	2.11e-06	7.9e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GSTA2—breast cancer	2.11e-06	7.89e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GPX2—breast cancer	2.11e-06	7.89e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PLA2G4A—breast cancer	2.1e-06	7.85e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NCOR1—breast cancer	2.1e-06	7.85e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—GPX1—breast cancer	2.09e-06	7.83e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—ITPR1—breast cancer	2.09e-06	7.81e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GPX4—breast cancer	2.08e-06	7.79e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—SULT1A1—breast cancer	2.08e-06	7.79e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CSF2—breast cancer	2.08e-06	7.76e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—FGF1—breast cancer	2.08e-06	7.76e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MMP3—breast cancer	2.07e-06	7.76e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—ERBB4—breast cancer	2.07e-06	7.76e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—STAT5A—breast cancer	2.07e-06	7.76e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CYP1A1—breast cancer	2.07e-06	7.75e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—RAF1—breast cancer	2.07e-06	7.74e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—PIK3CB—breast cancer	2.07e-06	7.74e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—MTHFR—breast cancer	2.06e-06	7.71e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NRG1—breast cancer	2.06e-06	7.71e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—ERCC2—breast cancer	2.06e-06	7.69e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—H2AFX—breast cancer	2.05e-06	7.65e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—IL2—breast cancer	2.04e-06	7.65e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GSTA1—breast cancer	2.04e-06	7.61e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—IDH1—breast cancer	2.04e-06	7.61e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—E2F1—breast cancer	2.03e-06	7.6e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—PIK3CB—breast cancer	2.02e-06	7.56e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—NAT2—breast cancer	2.01e-06	7.52e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—SMAD4—breast cancer	2.01e-06	7.51e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IGF1R—breast cancer	2e-06	7.47e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—PIK3CA—breast cancer	2e-06	7.46e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—CXCL8—breast cancer	1.99e-06	7.43e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—HES1—breast cancer	1.96e-06	7.34e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—SPP1—breast cancer	1.95e-06	7.3e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NCOR1—breast cancer	1.95e-06	7.29e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PLA2G4A—breast cancer	1.95e-06	7.29e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—CXCL8—breast cancer	1.94e-06	7.27e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—MTHFR—breast cancer	1.93e-06	7.23e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—TP53—breast cancer	1.93e-06	7.22e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—ERBB3—breast cancer	1.93e-06	7.22e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CSF2—breast cancer	1.93e-06	7.21e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—FGF1—breast cancer	1.93e-06	7.21e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—FGFR2—breast cancer	1.93e-06	7.21e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—RAF1—breast cancer	1.92e-06	7.2e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NRG1—breast cancer	1.91e-06	7.16e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CAV1—breast cancer	1.9e-06	7.11e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—H2AFX—breast cancer	1.9e-06	7.11e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—IL2—breast cancer	1.9e-06	7.1e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—E2F1—breast cancer	1.89e-06	7.06e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—PIK3CB—breast cancer	1.88e-06	7.03e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—IL2—breast cancer	1.86e-06	6.94e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—TERT—breast cancer	1.85e-06	6.92e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—HRAS—breast cancer	1.85e-06	6.9e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—SPP1—breast cancer	1.81e-06	6.78e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—CXCL8—breast cancer	1.81e-06	6.75e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—FGFR1—breast cancer	1.8e-06	6.72e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—ERBB3—breast cancer	1.79e-06	6.71e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—FGFR2—breast cancer	1.79e-06	6.7e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CAV1—breast cancer	1.78e-06	6.67e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—HIF1A—breast cancer	1.77e-06	6.62e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—MED12—breast cancer	1.76e-06	6.6e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—DPYD—breast cancer	1.76e-06	6.6e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ALDOA—breast cancer	1.74e-06	6.5e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PIK3CG—breast cancer	1.73e-06	6.48e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—LEP—breast cancer	1.73e-06	6.46e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—IL2—breast cancer	1.73e-06	6.45e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—TERT—breast cancer	1.72e-06	6.43e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CAV1—breast cancer	1.71e-06	6.4e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—KDR—breast cancer	1.69e-06	6.33e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—NCOA3—breast cancer	1.69e-06	6.31e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—SLC2A2—breast cancer	1.67e-06	6.26e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—FGFR1—breast cancer	1.67e-06	6.24e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—ESR1—breast cancer	1.65e-06	6.17e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—HIF1A—breast cancer	1.64e-06	6.15e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CPT1A—breast cancer	1.64e-06	6.13e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—MTR—breast cancer	1.64e-06	6.13e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ABCG2—breast cancer	1.64e-06	6.13e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—AKT1—breast cancer	1.63e-06	6.1e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—FN1—breast cancer	1.63e-06	6.09e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PIK3CG—breast cancer	1.62e-06	6.07e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NFKBIA—breast cancer	1.61e-06	6.02e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—HPGDS—breast cancer	1.61e-06	6.02e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—LEP—breast cancer	1.6e-06	6e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—HBA1—breast cancer	1.6e-06	5.98e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NOTCH1—breast cancer	1.59e-06	5.96e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CAV1—breast cancer	1.59e-06	5.95e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—KDR—breast cancer	1.57e-06	5.88e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ACHE—breast cancer	1.56e-06	5.83e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GSTT1—breast cancer	1.56e-06	5.83e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—KIT—breast cancer	1.56e-06	5.83e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—APC—breast cancer	1.56e-06	5.83e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PIK3CG—breast cancer	1.56e-06	5.83e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—EGF—breast cancer	1.54e-06	5.76e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—ESR1—breast cancer	1.53e-06	5.73e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PIK3CD—breast cancer	1.52e-06	5.69e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—FN1—breast cancer	1.51e-06	5.66e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—ALB—breast cancer	1.5e-06	5.62e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NFKBIA—breast cancer	1.5e-06	5.59e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—MAPK3—breast cancer	1.49e-06	5.58e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NOTCH1—breast cancer	1.48e-06	5.54e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CYP17A1—breast cancer	1.48e-06	5.52e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—BRAF—breast cancer	1.47e-06	5.48e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ENO1—breast cancer	1.46e-06	5.47e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PTGS1—breast cancer	1.46e-06	5.47e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—KIT—breast cancer	1.45e-06	5.42e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—APC—breast cancer	1.45e-06	5.42e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PIK3CG—breast cancer	1.45e-06	5.42e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—NOS3—breast cancer	1.44e-06	5.38e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CYP2D6—breast cancer	1.43e-06	5.36e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—EGF—breast cancer	1.43e-06	5.35e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PIK3CD—breast cancer	1.43e-06	5.34e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IGF1—breast cancer	1.43e-06	5.34e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—AKT2—breast cancer	1.43e-06	5.33e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—EGFR—breast cancer	1.42e-06	5.31e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—ALB—breast cancer	1.41e-06	5.27e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—NCOA2—breast cancer	1.41e-06	5.26e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—MAPK3—breast cancer	1.39e-06	5.19e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PIK3CD—breast cancer	1.37e-06	5.12e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—FASN—breast cancer	1.36e-06	5.1e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—BRAF—breast cancer	1.36e-06	5.09e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—BCHE—breast cancer	1.36e-06	5.08e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—PIK3CA—breast cancer	1.36e-06	5.08e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—SERPINE1—breast cancer	1.36e-06	5.07e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—NOS3—breast cancer	1.35e-06	5.04e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—SLC5A5—breast cancer	1.34e-06	5.02e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—KRAS—breast cancer	1.34e-06	5.02e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PIK3CB—breast cancer	1.33e-06	4.96e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IGF1—breast cancer	1.33e-06	4.96e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—AKT2—breast cancer	1.33e-06	4.96e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—EGFR—breast cancer	1.32e-06	4.93e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PTGS2—breast cancer	1.32e-06	4.92e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—SLC2A1—breast cancer	1.3e-06	4.85e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—NQO1—breast cancer	1.3e-06	4.85e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NOS3—breast cancer	1.29e-06	4.84e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PIK3CD—breast cancer	1.27e-06	4.76e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—PIK3CA—breast cancer	1.26e-06	4.72e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—SERPINE1—breast cancer	1.26e-06	4.71e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—KRAS—breast cancer	1.25e-06	4.66e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PIK3CB—breast cancer	1.24e-06	4.65e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CYP1B1—breast cancer	1.24e-06	4.65e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PTGS2—breast cancer	1.23e-06	4.61e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—PIK3CA—breast cancer	1.23e-06	4.61e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MDM2—breast cancer	1.23e-06	4.59e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—RAF1—breast cancer	1.22e-06	4.57e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.22e-06	4.56e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—RELA—breast cancer	1.22e-06	4.55e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—ERBB2—breast cancer	1.21e-06	4.53e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NOS3—breast cancer	1.2e-06	4.5e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MTOR—breast cancer	1.19e-06	4.47e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PIK3CB—breast cancer	1.19e-06	4.47e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—NCOA1—breast cancer	1.19e-06	4.43e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—STK11—breast cancer	1.17e-06	4.37e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CYP19A1—breast cancer	1.17e-06	4.37e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CXCL8—breast cancer	1.15e-06	4.29e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PTEN—breast cancer	1.15e-06	4.29e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—PIK3CA—breast cancer	1.15e-06	4.28e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MDM2—breast cancer	1.14e-06	4.27e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—HRAS—breast cancer	1.14e-06	4.26e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—RAF1—breast cancer	1.14e-06	4.25e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—RELA—breast cancer	1.13e-06	4.23e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—ERBB2—breast cancer	1.12e-06	4.21e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CDKN1B—breast cancer	1.12e-06	4.19e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MTOR—breast cancer	1.11e-06	4.15e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PIK3CB—breast cancer	1.11e-06	4.15e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—AKT1—breast cancer	1.11e-06	4.15e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CASP3—breast cancer	1.1e-06	4.11e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IL2—breast cancer	1.1e-06	4.1e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—IL6—breast cancer	1.09e-06	4.08e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—COMT—breast cancer	1.09e-06	4.06e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GSTP1—breast cancer	1.08e-06	4.04e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PTEN—breast cancer	1.08e-06	4.02e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CCND1—breast cancer	1.07e-06	4e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—JUN—breast cancer	1.07e-06	3.99e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—HMOX1—breast cancer	1.07e-06	3.99e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CXCL8—breast cancer	1.07e-06	3.99e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ITPR1—breast cancer	1.06e-06	3.98e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—HRAS—breast cancer	1.06e-06	3.96e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CTNNB1—breast cancer	1.06e-06	3.96e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CDKN1B—breast cancer	1.04e-06	3.89e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MMP9—breast cancer	1.04e-06	3.88e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CDKN1A—breast cancer	1.03e-06	3.87e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PTEN—breast cancer	1.03e-06	3.86e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—AKT1—breast cancer	1.03e-06	3.85e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ABCB1—breast cancer	1.02e-06	3.83e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CASP3—breast cancer	1.02e-06	3.82e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IL2—breast cancer	1.02e-06	3.81e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—IL6—breast cancer	1.01e-06	3.79e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MAPK8—breast cancer	1.01e-06	3.78e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—AKT1—breast cancer	1.01e-06	3.77e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—TYMS—breast cancer	1.01e-06	3.76e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PLA2G4A—breast cancer	9.94e-07	3.72e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—NCOR1—breast cancer	9.94e-07	3.72e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GSTM1—breast cancer	9.94e-07	3.72e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CCND1—breast cancer	9.94e-07	3.72e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—JUN—breast cancer	9.91e-07	3.71e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CTNNB1—breast cancer	9.84e-07	3.68e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MMP9—breast cancer	9.65e-07	3.61e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CDKN1A—breast cancer	9.61e-07	3.59e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PTEN—breast cancer	9.59e-07	3.59e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—SRC—breast cancer	9.57e-07	3.58e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GPX1—breast cancer	9.52e-07	3.56e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CYP1A1—breast cancer	9.42e-07	3.52e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MAPK8—breast cancer	9.38e-07	3.51e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—AKT1—breast cancer	9.36e-07	3.5e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ERCC2—breast cancer	9.34e-07	3.49e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—VEGFA—breast cancer	9.32e-07	3.49e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—STAT3—breast cancer	9.23e-07	3.45e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—SRC—breast cancer	8.89e-07	3.33e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MAPK3—breast cancer	8.82e-07	3.3e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—MTHFR—breast cancer	8.78e-07	3.28e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—VEGFA—breast cancer	8.66e-07	3.24e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MYC—breast cancer	8.58e-07	3.21e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—STAT3—breast cancer	8.58e-07	3.21e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—TGFB1—breast cancer	8.56e-07	3.2e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—EGFR—breast cancer	8.39e-07	3.14e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MAPK3—breast cancer	8.19e-07	3.06e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CAV1—breast cancer	8.1e-07	3.03e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PIK3CA—breast cancer	8.09e-07	3.03e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MYC—breast cancer	7.97e-07	2.98e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—TGFB1—breast cancer	7.95e-07	2.97e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—KRAS—breast cancer	7.93e-07	2.96e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—EGFR—breast cancer	7.8e-07	2.91e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PIK3CA—breast cancer	7.59e-07	2.84e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PIK3CG—breast cancer	7.38e-07	2.76e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—KRAS—breast cancer	7.36e-07	2.75e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PIK3CA—breast cancer	7.28e-07	2.72e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—TP53—breast cancer	7.04e-07	2.63e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PIK3CA—breast cancer	6.77e-07	2.53e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—HRAS—breast cancer	6.74e-07	2.52e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—AKT1—breast cancer	6.61e-07	2.47e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—TP53—breast cancer	6.54e-07	2.45e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PIK3CD—breast cancer	6.49e-07	2.43e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IL6—breast cancer	6.45e-07	2.41e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ALB—breast cancer	6.4e-07	2.39e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—HRAS—breast cancer	6.26e-07	2.34e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—AKT1—breast cancer	6.2e-07	2.32e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—NOS3—breast cancer	6.13e-07	2.29e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IL6—breast cancer	5.99e-07	2.24e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—AKT1—breast cancer	5.95e-07	2.22e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PIK3CB—breast cancer	5.65e-07	2.11e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PTGS2—breast cancer	5.6e-07	2.1e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—AKT1—breast cancer	5.53e-07	2.07e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PTEN—breast cancer	4.89e-07	1.83e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PIK3CA—breast cancer	3.45e-07	1.29e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—AKT1—breast cancer	2.82e-07	1.05e-05	CbGpPWpGaD
